The latest figures from the National Drug-Related Deaths Index (NDRDI) show that a total of 679 deaths in Ireland during 2013 were linked to drug use
Archives for February 2016
Bibliography: All Publications
Data on clients seen at drug and alcohol treatment agencies
July to September 2015. Quarterly data are published on StatsWales. These include data on quarterly activity, case closures by reason for closure and the time between referral and start of treatment (Welsh Government)
Availability of Internationally Controlled Drugs
Ensuring Adequate Access for Medical and Scientific Purposes (INCB)
Report on an announced inspection of HMP Ranby
The prison was attempting to combat a surge in the availability of new psychoactive substances (NPS); 58% of prisoners told us it was easy to get drugs in the prison. Health services were at risk of being overwhelmed by the need to treat the most seriously affected and as we walked round the prison, we saw a number of prisoners who were clearly under the influence of NPS (HM Chief Inspector of Prisons)
Club Drug Use Among Lesbian, Gay, Bisexual and Trans (LGBT) People
This document focuses on LGBT populations and is intended to guide improved service and treatment planning. It describes patterns of club drug use among these sub-populations (Neptune)
From Epidemic to Evidence
Effectively Managing The Harms Associated with Crystal Methamphetamine (Drug and Alcohol Research Connections)
Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England
The distribution of THN within a custodial setting requires consideration of a number of important factors which are discussed (HRJ)
After the Drug Wars
Report of the LSE Expert Group on the Economics of Drug Policy
United Kingdom Drug Situation
Annual Report to the European Monitoring Centre for Drugs and Drug Addiction (UK Focal Point On Drugs)
New Report and Monitoring Tool: HIV, HCV, TB and Harm Reduction in Prisons
Even though prisoners do not forfeit their human rights, such as the right to health, there is an enormous gap between health and human rights standards and their effective implementation in places of detention (IHR)
Road to Success: Towards Sustainable Harm Reduction Financing
This report provides guidance, driven by findings from the community of people who inject drugs and their allies, for countries and international partners alike to make this transition (EHRN)
The internet and drug markets
This first EMCDDA investigation into the world of online drug markets brings together state-of-the-art input from over 20 experts — from academia, journalism and frontline practice — and contributes to the knowledge base on this part of the supply chain
Drug Crop Production, Poverty, and Development
This series intends to provide a primer on why governments must not turn a blind eye to pressing human rights and public health impacts of current drug policies (OSF)
EMCDDA activities in the area of emergencies
A unique insight into acute health harms is provided by hospital emergency data, which widen the scope of monitoring health consequences of drug use, beyond other more established indicators (EMCDDA)
Investigating the role of benzodiazepines in drug-related mortalit
A systematic review undertaken on behalf of The Scottish National Forum on Drug-Related Deaths (ScotPHO)
The absorption of recovery in English drug policy
This is an excerpt of a recent NDARC seminar presentation by Professor Alex Stevens (NDARC)
Annual Parliamentary Hearing
“The world drug problem: taking stock and strengthening the global response” (UNODC)
Impact of the reduction in heroin supply between 2010 and 2011
This report makes best use of available secondary data to examine how the reduction in heroin supply in England and Wales manifested itself at street level and to attempt to quantify any impact on drug use and associated harms (Home Office)
Availability of Internationally Controlled Drugs
Ensuring Adequate Access for Medical and Scientific Purposes (INCB)
PHILTRE Annual Report 2014-15
WEDINOS provides a mechanism for the anonymous submission and testing of samples of new psychoactive substances and the dissemination of pragmatic harm reduction advice (NHS Wales)